S&P 500   4,256.37 (+1.17%)
DOW   33,625.30 (+0.87%)
QQQ   328.47 (+1.35%)
AAPL   171.38 (+1.72%)
MSFT   289.86 (+0.99%)
META   179.51 (+1.14%)
GOOGL   120.44 (+1.35%)
AMZN   141.47 (+0.59%)
TSLA   886.74 (+3.12%)
NVDA   185.26 (+3.25%)
NIO   20.96 (+0.67%)
BABA   94.36 (-0.54%)
AMD   100.62 (+2.55%)
MU   65.12 (+4.49%)
T   18.19 (+0.83%)
CGC   3.29 (+4.44%)
GE   79.20 (+0.38%)
F   16.08 (+1.58%)
DIS   120.69 (+2.55%)
AMC   25.36 (-0.39%)
PYPL   100.70 (+1.60%)
PFE   49.99 (+3.52%)
NFLX   246.57 (+1.59%)
S&P 500   4,256.37 (+1.17%)
DOW   33,625.30 (+0.87%)
QQQ   328.47 (+1.35%)
AAPL   171.38 (+1.72%)
MSFT   289.86 (+0.99%)
META   179.51 (+1.14%)
GOOGL   120.44 (+1.35%)
AMZN   141.47 (+0.59%)
TSLA   886.74 (+3.12%)
NVDA   185.26 (+3.25%)
NIO   20.96 (+0.67%)
BABA   94.36 (-0.54%)
AMD   100.62 (+2.55%)
MU   65.12 (+4.49%)
T   18.19 (+0.83%)
CGC   3.29 (+4.44%)
GE   79.20 (+0.38%)
F   16.08 (+1.58%)
DIS   120.69 (+2.55%)
AMC   25.36 (-0.39%)
PYPL   100.70 (+1.60%)
PFE   49.99 (+3.52%)
NFLX   246.57 (+1.59%)
S&P 500   4,256.37 (+1.17%)
DOW   33,625.30 (+0.87%)
QQQ   328.47 (+1.35%)
AAPL   171.38 (+1.72%)
MSFT   289.86 (+0.99%)
META   179.51 (+1.14%)
GOOGL   120.44 (+1.35%)
AMZN   141.47 (+0.59%)
TSLA   886.74 (+3.12%)
NVDA   185.26 (+3.25%)
NIO   20.96 (+0.67%)
BABA   94.36 (-0.54%)
AMD   100.62 (+2.55%)
MU   65.12 (+4.49%)
T   18.19 (+0.83%)
CGC   3.29 (+4.44%)
GE   79.20 (+0.38%)
F   16.08 (+1.58%)
DIS   120.69 (+2.55%)
AMC   25.36 (-0.39%)
PYPL   100.70 (+1.60%)
PFE   49.99 (+3.52%)
NFLX   246.57 (+1.59%)
S&P 500   4,256.37 (+1.17%)
DOW   33,625.30 (+0.87%)
QQQ   328.47 (+1.35%)
AAPL   171.38 (+1.72%)
MSFT   289.86 (+0.99%)
META   179.51 (+1.14%)
GOOGL   120.44 (+1.35%)
AMZN   141.47 (+0.59%)
TSLA   886.74 (+3.12%)
NVDA   185.26 (+3.25%)
NIO   20.96 (+0.67%)
BABA   94.36 (-0.54%)
AMD   100.62 (+2.55%)
MU   65.12 (+4.49%)
T   18.19 (+0.83%)
CGC   3.29 (+4.44%)
GE   79.20 (+0.38%)
F   16.08 (+1.58%)
DIS   120.69 (+2.55%)
AMC   25.36 (-0.39%)
PYPL   100.70 (+1.60%)
PFE   49.99 (+3.52%)
NFLX   246.57 (+1.59%)
LON:IBT

International Biotechnology Trust - IBT Share Forecast, Price & News

GBX 703
-1.00 (-0.14%)
(As of 08/12/2022 04:35 PM ET)
Add
Compare
Today's Range
695
715
50-Day Range
606
710
52-Week Range
563
773.25
Volume
31,838 shs
Average Volume
70,505 shs
Market Capitalization
£287.27 million
P/E Ratio
N/A
Dividend Yield
4.49%
Price Target
GBX 260
IBT stock logo

About International Biotechnology Trust (LON:IBT) Stock

International Biotechnology Trust plc specializes in investments in development stage and late stage companies. The majority of the fund's assets are generally invested in smaller and mid-capitalization quoted companies, with a minority in larger capitalization quoted companies. It makes long only investments. It prefers to invest in quoted or unquoted biotechnology and life sciences companies focused on drug discovery and development and in related sectors such as microbiology, life sciences, pharmaceutical research and development, gene research and development, medical devices or healthcare services. The fund seeks to invest in companies engaged in development and/or commercialization of a product, device or enabling technology and also invests in the therapeutic sub-sector. The fund also prefers to invest in companies with strong growth potential from the development and/or commercialization of either a biotechnology drug candidate, medical device or other enabling technology for medical research. It may also invest in specialty pharmaceuticals and life science tools. These companies can range from small private companies with strong science and people that need development funding, to large, multi-billion dollar biotechnology and medical device companies which have portfolios of products, many of which are already used in hospitals, clinics and pharmacies around the world. It makes majority of its investments in smaller and mid-capitalization quoted companies and seeks to invest up to thirty percent of the Company's assets in unquoted companies, while allowing an exposure of up to forty percent in unquoted companies (at the time of investment and after allowing for valuation write-ups and further follow-on investments). The fund typically invests in the United States, but seeks the best investments worldwide and so may also invest in Western Europe, Australia, and Asia. It typically invests between $1 million and $4 million in its portfolio companies. It exits its unquoted investments through the sale of these companies to strategic buyers including major pharmaceutical companies or, in some cases, and through a flotation.

International Biotechnology Trust Stock Up 0.7 %

Shares of IBT traded up GBX 5 ($0.06) during trading hours on Thursday, reaching GBX 704 ($8.51). The company's stock had a trading volume of 54,343 shares, compared to its average volume of 70,758. The company has a quick ratio of 0.00, a current ratio of 0.00 and a debt-to-equity ratio of 16.90. International Biotechnology Trust has a 1-year low of GBX 563 ($6.80) and a 1-year high of GBX 773.25 ($9.34). The company has a 50 day moving average of GBX 667.28 and a two-hundred day moving average of GBX 648.27. The firm has a market cap of £287.68 million and a price-to-earnings ratio of -7.30.

International Biotechnology Trust Announces Dividend

The business also recently disclosed a dividend, which will be paid on Friday, August 26th. Stockholders of record on Thursday, August 4th will be paid a GBX 15.70 ($0.19) dividend. The ex-dividend date is Thursday, August 4th. This represents a dividend yield of 2.27%. International Biotechnology Trust's dividend payout ratio is currently -0.31%.

Receive IBT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for International Biotechnology Trust and its competitors with MarketBeat's FREE daily newsletter.

IBT Stock News Headlines

Int.biotech. Share Chat
International Biotechnology Trust plc (IBT.L)
Trade-Van Information Services Co. Ltd.
Nutrition21's nooLVL® Earns Top Spot in Player1 Launch
Govt too quick to use S112
See More Headlines
Receive IBT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for International Biotechnology Trust and its competitors with MarketBeat's FREE daily newsletter.

IBT Company Calendar

Ex-Dividend for 8/26 Dividend
8/04/2022
Today
8/12/2022
Dividend Payable
8/26/2022
Next Earnings (Estimated)
10/31/2022

Industry, Sector and Symbol

Industry
Asset Management
Sub-Industry
N/A
Sector
Finance
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
GBX 260
High Stock Price Forecast
GBX 260
Low Stock Price Forecast
GBX 260
Forecasted Upside/Downside
-63.0%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£-34,757,000.00
Cash Flow
GBX 4.51 per share
Book Value
GBX 648.80 per share

Miscellaneous

Free Float
N/A
Market Cap
£287.27 million
Optionable
Not Optionable
Beta
N/A














IBT Stock - Frequently Asked Questions

Should I buy or sell International Biotechnology Trust stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for International Biotechnology Trust in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" IBT shares.
View IBT analyst ratings
or view top-rated stocks.

What is International Biotechnology Trust's stock price forecast for 2022?

1 equities research analysts have issued twelve-month price objectives for International Biotechnology Trust's shares. Their IBT share price forecasts range from GBX 260 to GBX 260. On average, they anticipate the company's share price to reach GBX 260 in the next twelve months. This suggests that the stock has a possible downside of 62.9%.
View analysts price targets for IBT
or view top-rated stocks among Wall Street analysts.

How have IBT shares performed in 2022?

International Biotechnology Trust's stock was trading at GBX 747.50 at the beginning of the year. Since then, IBT stock has decreased by 6.3% and is now trading at GBX 700.10.
View the best growth stocks for 2022 here
.

When is International Biotechnology Trust's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, October 31st 2022.
View our IBT earnings forecast
.

How often does International Biotechnology Trust pay dividends? What is the dividend yield for International Biotechnology Trust?

International Biotechnology Trust announced a dividend on Friday, July 22nd. Shareholders of record on Thursday, August 4th will be given a dividend of GBX 15.70 per share on Friday, August 26th. This represents a yield of 2.27%. The ex-dividend date of this dividend is Thursday, August 4th. The official announcement can be accessed at this link.
Read our dividend analysis for IBT
.

Is International Biotechnology Trust a good dividend stock?

International Biotechnology Trust (LON:IBT) pays an annual dividend of GBX 0.30 per share and currently has a dividend yield of 4.50%. IBT has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer.
Read our dividend analysis for IBT.

What other stocks do shareholders of International Biotechnology Trust own?

Based on aggregate information from My MarketBeat watchlists, some companies that other International Biotechnology Trust investors own include Oxford Pharmascience Group (OXP), Provident Financial (PFG), 1724525 (ADN.L) (ADN), The Berkeley Group (BKG), GLI Finance (GLIF), Hurricane Energy (HUR), Phoenix Group (PHNX), Riverstone Energy (RSE), Scirocco Energy Plc (SOLO.L) (SOLO) and Sirius Minerals (SXX).

What is International Biotechnology Trust's stock symbol?

International Biotechnology Trust trades on the London Stock Exchange (LON) under the ticker symbol "IBT."

How do I buy shares of International Biotechnology Trust?

Shares of IBT stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is International Biotechnology Trust's stock price today?

One share of IBT stock can currently be purchased for approximately GBX 700.10.

How much money does International Biotechnology Trust make?

International Biotechnology Trust (LON:IBT) has a market capitalization of £286.08 million and generates £-34,757,000.00 in revenue each year.

How can I contact International Biotechnology Trust?

International Biotechnology Trust's mailing address is 10 Harewood Avenue, LONDON, NW1 6AA, United Kingdom. The official website for the company is www.ibtplc.com. The company can be reached via phone at 44 20 7421 7070.

This page (LON:IBT) was last updated on 8/12/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.